CVS/$CVS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CVS
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Ticker
$CVS
Sector
Primary listing
NYSE
Employees
259,500
Headquarters
Website
CVS Metrics
BasicAdvanced
$91B
51.70
$1.39
0.46
$2.66
3.70%
Price and volume
Market cap
$91B
Beta
0.46
52-week high
$85.15
52-week low
$58.35
Average daily volume
8M
Dividend rate
$2.66
Financial strength
Current ratio
0.842
Quick ratio
0.568
Long term debt to equity
98.359
Total debt to equity
106.06
Dividend payout ratio (TTM)
192.14%
Interest coverage (TTM)
3.21%
Profitability
EBITDA (TTM)
14,625
Gross margin (TTM)
13.29%
Net profit margin (TTM)
0.44%
Operating margin (TTM)
2.51%
Effective tax rate (TTM)
19.10%
Revenue per employee (TTM)
$1,540,000
Management effectiveness
Return on assets (TTM)
2.47%
Return on equity (TTM)
2.29%
Valuation
Price to earnings (TTM)
51.698
Price to revenue (TTM)
0.228
Price to book
1.21
Price to tangible book (TTM)
-2.55
Price to free cash flow (TTM)
11.662
Free cash flow yield (TTM)
8.57%
Free cash flow per share (TTM)
6.162
Dividend yield (TTM)
3.70%
Forward dividend yield
3.70%
Growth
Revenue change (TTM)
7.87%
Earnings per share change (TTM)
-62.02%
3-year revenue growth (CAGR)
7.52%
10-year revenue growth (CAGR)
10.06%
3-year earnings per share growth (CAGR)
-24.73%
10-year earnings per share growth (CAGR)
-11.33%
3-year dividend per share growth (CAGR)
6.53%
10-year dividend per share growth (CAGR)
6.63%
What the Analysts think about CVS
Analyst ratings (Buy, Hold, Sell) for CVS stock.
CVS Financial Performance
Revenues and expenses
CVS Earnings Performance
Company profitability
CVS News
AllArticlesVideos
Bernstein Litowitz Berger & Grossmann Announces Filing of Racketeering Class Action Against CaremarkPCS and CVS Health Corporation
Business Wire·20 hours ago
CVS Health's Aetna to Pay $117.7 Million to Resolve False Claims Act Allegations
WSJ·1 week ago
CVS taps Google Cloud to roll out AI-powered health platform
Reuters·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for CVS stock?
CVS (CVS) has a market cap of $91B as of March 20, 2026.
What is the P/E ratio for CVS stock?
The price to earnings (P/E) ratio for CVS (CVS) stock is 51.7 as of March 20, 2026.
Does CVS stock pay dividends?
Yes, the CVS (CVS) stock pays dividends to shareholders. As of March 20, 2026, the dividend rate is $2.66 and the yield is 3.7%. CVS has a payout ratio of 192.14% on a trailing twelve-month basis.
When is the next CVS dividend payment date?
The next CVS (CVS) dividend payment is scheduled for May 04, 2026.
What is the beta indicator for CVS?
CVS (CVS) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.